Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
10.5
5.2
Journals
Cells
Announcements
share announcement

Announcements

25 August 2025
Cells | Highly Cited Papers Published in 2024 in the “Cellular Pathology” Section


The “Cellular Pathology” Section of Cells (ISSN: 2073-4409) focuses on cellular pathology, molecular mechanisms of diseases, and the characterization of cellular pathways relevant to pathogenic processes. We encourage the submission of manuscripts (original data and reviews) that address all aspects of cellular pathology, including those related to mechanisms of genetic, infectious, or acquired diseases, autoimmune disorders, ageing, and cellular damage through extrinsic causes. We particularly seek submissions that provide novel insights and/or concepts to advance the field of cellular pathology in human diseases.

Our readers can enjoy free and unlimited access to the full texts of all of the open access articles published in our journal. We welcome you to read our most highly cited papers published in 2024 below:

1. “Role of the Skin Immune System in Wound Healing”
by Angela Cioce, Andrea Cavani, Caterina Cattani and Fernanda Scopelliti
Cells 2024, 13(7), 624; https://doi.org/10.3390/cells13070624
Available online: https://www.mdpi.com/2073-4409/13/7/624

2. “Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer”
by Patrick W. Underwood, Samantha M. Ruff and Timothy M. Pawlik
Cells 2024, 13(3), 245; https://doi.org/10.3390/cells13030245
Available online: https://www.mdpi.com/2073-4409/13/3/245

3. “ICAMs in Immunity, Intercellular Adhesion and Communication”
by Claudia Guerra-Espinosa, María Jiménez-Fernández, Francisco Sánchez-Madrid and Juan M. Serrador
Cells 2024, 13(4), 339; https://doi.org/10.3390/cells13040339
Available online: https://www.mdpi.com/2073-4409/13/4/339

4. “The Role of Transforming Growth Factor-β (TGF-β) in Asthma and Chronic Obstructive Pulmonary Disease (COPD)”
by Krzysztof Kraik, Maciej Tota, Julia Laska, Julia Łacwik, Łukasz Paździerz, Łukasz Sędek and Krzysztof Gomułka
Cells 2024, 13(15), 1271; https://doi.org/10.3390/cells13151271
Available online: https://www.mdpi.com/2073-4409/13/15/1271

5. “Targeting Interactions between Fibroblasts and Macrophages to Treat Cardiac Fibrosis”
by Bo Yang, Yan Qiao, Dong Yan and Qinghang Meng
Cells 2024, 13(9), 764; https://doi.org/10.3390/cells13090764
Available online: https://www.mdpi.com/2073-4409/13/9/764

6. “Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises”
by Bandini Sara, Paola Ulivi and Tania Rossi
Cells 2024, 13(4), 337. https://doi.org/10.3390/cells13040337
Available online: https://www.mdpi.com/2073-4409/13/4/337

7. “Hypercalcemia in Cancer: Causes, Effects, and Treatment Strategies”
by Patrycja Bartkiewicz, Dominika Kunachowicz, Michał Filipski, Agata Stebel, Julia Ligoda and Nina Rembiałkowska
Cells 2024, 13(12), 1051. https://doi.org/10.3390/cells13121051
Available online: https://www.mdpi.com/2073-4409/13/12/1051

8. “Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy”
by Jose-Andres C. Portillo, Amelia Pfaff, Sarah Vos, Matthew Weng, Ram H. Nagaraj and Carlos S. Subauste
Cells 2024, 13(5), 429. https://doi.org/10.3390/cells13050429
Available online: https://www.mdpi.com/2073-4409/13/5/429

9. “Molecular Characterization and Subtyping of Breast Cancer Cell Lines Provide Novel Insights into Cancer Relevant Genes”
by Claudia Pommerenke, Stefan Nagel, Josephine Haake, Anne Leena Koelz, Matthias Christgen, Laura Steenpass and Sonja Eberth
Cells 2024, 13(4), 301. https://doi.org/10.3390/cells13040301
Available online: https://www.mdpi.com/2073-4409/13/4/301

10. “Immune Cell Migration to Cancer”
by Allison T. Ryan, Minsoo Kim and Kihong Lim
Cells 2024, 13(10), 844. https://doi.org/10.3390/cells13100844
Available online: https://www.mdpi.com/2073-4409/13/10/844

More News...
Back to TopTop